These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 6093132
21. Relation between Na+-K+-ATPase activity and dopamine release from rat striatum slices. Fischer HG, Rudolph E, Schmidt J. Acta Biol Med Ger; 1982; 41(5):471-6. PubMed ID: 6291291 [Abstract] [Full Text] [Related]
22. Characterization of ouabain receptor in neuronal tissue: evidence for endogenous ouabain-like compound. Lichtstein D, Samuelov S. Isr J Med Sci; 1982 Jan; 18(1):45-50. PubMed ID: 6121774 [Abstract] [Full Text] [Related]
23. Dopaminergic--GABA-ergic interaction in the nigrostriatal system. Koltai MZ, György L. Acta Physiol Acad Sci Hung; 1981 Jan; 58(3):225-33. PubMed ID: 7348023 [Abstract] [Full Text] [Related]
24. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor. Choi-Lundberg DL, Lin Q, Schallert T, Crippens D, Davidson BL, Chang YN, Chiang YL, Qian J, Bardwaj L, Bohn MC. Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166 [Abstract] [Full Text] [Related]
30. Evidence for, and localization of, a unitary dopamine receptor composed of cooperatively linked subunit binding sites in rat striatum. Leysen JE, Gommeren W, Laduron PM. Arch Int Pharmacodyn Ther; 1979 Dec; 242(2):312-4. PubMed ID: 543764 [No Abstract] [Full Text] [Related]
31. High affinity and low affinity ouabain binding sites in the rat heart. Akera T, Ng YC, Hadley R, Katano Y, Brody TM. Eur J Pharmacol; 1986 Dec 16; 132(2-3):137-46. PubMed ID: 3028836 [Abstract] [Full Text] [Related]
32. Change in catecholamine-sensitive Na+,K+-ATPase activity in the rat striatum microsomes following electrolytic or 6-hydroxydopamine-induced lesions of dopaminergic neurons. Kamata K, Kamata M, Ino H, Kameyama T. Jpn J Pharmacol; 1980 Jun 16; 30(3):401-4. PubMed ID: 6256571 [No Abstract] [Full Text] [Related]
33. Dopamine depletion protects striatal neurons from ischemia-induced cell death. Clemens JA, Phebus LA. Life Sci; 1988 Jun 16; 42(6):707-13. PubMed ID: 3123836 [Abstract] [Full Text] [Related]
36. The brain's dopamine receptor: labeling with (3H) dopamine and (3H) haloperidol. Snyder SH, Creese I, Burt DR. Psychopharmacol Commun; 1975 Jun 16; 1(6):663-73. PubMed ID: 1241457 [No Abstract] [Full Text] [Related]
37. The sodium-potassium ATPase inhibitor ouabain is neurotoxic in the rat substantia nigra and striatum. Lees GJ, Leong W. Neurosci Lett; 1995 Mar 24; 188(2):113-6. PubMed ID: 7540738 [Abstract] [Full Text] [Related]
38. Long-term effects of nigro-striatal denervation of striatal [3H]haloperidol binding. Feuerstein C, Demenge P, Barrette G, Silice C, Guerin B, Mouchet P. Eur J Pharmacol; 1981 Dec 17; 76(4):457-60. PubMed ID: 6799306 [No Abstract] [Full Text] [Related]
39. Chronic modification of dopaminergic transmission and its effects on binding characteristics of dopamine transporter ligand 3H-GBR 12783 in the striatum. Valchár M, Bonnet JJ, Costentin J. Act Nerv Super (Praha); 1989 Dec 17; 31(4):273-4. PubMed ID: 2561622 [No Abstract] [Full Text] [Related]
40. Characterization and localization of catecholamine-susceptible Na-K ATPase activity of rat striatum: studies using catecholamine receptor (ant)agonists and lesion techniques. van der Krogt JA, Belfroid RD. Biochem Pharmacol; 1980 Mar 15; 29(6):857-68. PubMed ID: 6248069 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]